title: [The use of antiemetics in cancer chemotherapy].
abstract: The development of new chemotherapeutic protocols especially those cisplatin containing regimens, has lead to a dramatic improvement of remission rates in certain cancers. Nausea and vomiting seems to be the most distressing side effect from the patients point of view. A good administration of classical anti-emetic drugs should yield to at least 50% of good protection. The introduction of new drugs should even give more protection to our patients.
authors.affiliation: Université Saint-Joseph, Beyrouth, Liban.
authors.forename: M
authors.initials: M
authors.lastname: Ghosn
authors.forename: J P
authors.initials: JP
authors.lastname: Droz
mesh_terms: D000932:Antiemetics / Q000494:pharmacology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002985:Clinical Protocols; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D009369:Neoplasms / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D000932:Antiemetics; D000970:Antineoplastic Agents
vernacular_title: L'utilisation des anti-émétiques dans la chimiothérapie du cancer.